Sign in to confirm you’re not a bot
This helps protect our community. Learn more
Meet Ukko - A Leaps Portfolio Company
10Likes
51,322Views
2021May 12
Ukko wants to improve the lives of the millions who suffer from food allergies and sensitivities. This Leaps by Bayer portfolio company uses immunology, machine learning and protein engineering to make measurably better and safer. With an A.I.-powered protein design platform, they are engineering gluten with all positive characteristics of traditional gluten but without triggering the immune system. Ukko is also working on a unique therapy for peanut allergy sufferers. Discover Ukko’s CEO Anat Binur and Co-founder Yanay Orfan explaining their approach to overcoming food allergies and sensitivities. Learn more about Ukko: https://leaps.bayer.com/companies?sho... https://www.ukko.us/ About us: Leaps by Bayer invests in paradigm-shifting advances in the life sciences – targeting the breakthroughs that could fundamentally change the world for the better. Our approach is making significant and sustained investments in disruptive biotechnologies that could have the greatest impact on humanity. Connect with us: https://leaps.bayer.com/   / leapsbybayer     / leapsbybayer   Subscribe to our channel for more on breakthroughs in health and agriculture: https://bit.ly/2PJvazz

Follow along using the transcript.

Leaps by Bayer

6.22K subscribers